Genomic-guided precision therapy for soft tissue sarcoma

Soft tissue sarcoma (STS), although heterogeneous in histopathology presentation, has mostly been treated with chemotherapy agents as one entity. Our understanding of crucial genomic alterations in different STS histologies and the advent of molecular-targeted agents have reshaped the treatment para...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsing-Wu, Chen, Tom Wei-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059546/
https://www.ncbi.nlm.nih.gov/pubmed/32132106
http://dx.doi.org/10.1136/esmoopen-2019-000626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059546/
https://www.ncbi.nlm.nih.gov/pubmed/32132106
http://dx.doi.org/10.1136/esmoopen-2019-000626

Ejemplares similares